Ovarian Cancer Recurrent Clinical Trials in Manchester
2 recruitingManchester, United Kingdom
Showing 1–2 of 2 trials
Recruiting
Phase 1Phase 2
A Clinical Study of Raludotatug Deruxtecan in People With Ovarian Cancer (MK-5909-003)
Ovarian Cancer Recurrent
Merck Sharp & Dohme LLC460 enrolled23 locationsNCT06843447
Recruiting
Phase 2
SBRT Alone or Followed by Niraparib for Oligometastases or Oligoprogression in Ovarian Cancer Following PARPi Therapy
Ovarian Cancer Recurrent
Institute of Cancer Research, United Kingdom42 enrolled5 locationsNCT05990192